Intervacc AB (publ) (IVACC.ST)

SEK 2.38

(4.39%)

Eps Summary of Intervacc AB (publ)

  • Intervacc AB (publ)'s latest annual eps in 2023 was -1.69 SEK , down -52.25% from previous year.
  • Intervacc AB (publ)'s latest quarterly eps in 2024 Q2 was -0.24 SEK , down -4.35% from previous quarter.
  • Intervacc AB (publ) reported an annual eps of -1.11 SEK in 2022, down -117.65% from previous year.
  • Intervacc AB (publ) reported an annual eps of -0.51 SEK in 2021, down -8.51% from previous year.
  • Intervacc AB (publ) reported a quarterly eps of -0.23 SEK for 2024 Q1, up 11.54% from previous quarter.
  • Intervacc AB (publ) reported a quarterly eps of -0.30 SEK for 2023 Q1, up 25.0% from previous quarter.

Annual Eps Chart of Intervacc AB (publ) (2023 - 2013)

Historical Annual Eps of Intervacc AB (publ) (2023 - 2013)

Year Eps Eps Growth
2023 -1.69 SEK -52.25%
2022 -1.11 SEK -117.65%
2021 -0.51 SEK -8.51%
2020 -0.47 SEK 24.19%
2019 -0.62 SEK 20.51%
2018 -0.78 SEK -13.04%
2017 -0.69 SEK -35.29%
2016 -0.51 SEK -10100.0%
2015 0.01 SEK -98.54%
2014 0.35 SEK 511.76%
2013 -0.08 SEK 0.0%

Peer Eps Comparison of Intervacc AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK -207.273%
Ziccum AB (publ) -1.54 SEK -9.74%
Modus Therapeutics Holding AB (publ) -1.01 SEK -67.327%
BioArctic AB (publ) 2.60 SEK 165.0%
Sprint Bioscience AB (publ) -0.01 SEK -26725.397%
Mendus AB (publ) -4.40 SEK 61.591%
Genovis AB (publ.) 0.94 SEK 279.787%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -668.182%
Active Biotech AB (publ) -0.17 SEK -894.118%
Magle Chemoswed Holding AB (publ) 1.13 SEK 249.558%
Bio-Works Technologies AB (publ) -1.57 SEK -7.643%
Aptahem AB (publ) -0.05 SEK -3398.965%
Vicore Pharma Holding AB (publ) -3.22 SEK 47.516%
Kancera AB (publ) -0.80 SEK -111.25%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 83.015%
Fluicell AB (publ) -0.24 SEK -604.167%
Saniona AB (publ) -1.29 SEK -31.008%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -789.474%
Biovica International AB (publ) -2.14 SEK 21.028%
Spago Nanomedical AB (publ) -0.43 SEK -293.023%
AcouSort AB (publ) -1.29 SEK -31.008%
Xintela AB (publ) -0.13 SEK -1200.0%
Abliva AB (publ) -0.09 SEK -1769.469%
Egetis Therapeutics AB (publ) -1.27 SEK -33.071%
Karolinska Development AB (publ) 0.02 SEK 8550.0%
OncoZenge AB (publ) -1.36 SEK -24.265%
Amniotics AB (publ) -0.01 SEK -15263.636%
2cureX AB (publ) -1.85 SEK 8.649%
CombiGene AB (publ) -1.80 SEK 6.111%
Asarina Pharma AB (publ) -0.57 SEK -196.491%
Calliditas Therapeutics AB (publ) -8.69 SEK 80.552%
Camurus AB (publ) 7.78 SEK 121.722%
Corline Biomedical AB -0.08 SEK -1907.126%
IRLAB Therapeutics AB (publ) -3.43 SEK 50.729%
Isofol Medical AB (publ) -0.23 SEK -634.783%
I-Tech AB 1.70 SEK 199.412%
Hansa Biopharma AB (publ) -15.83 SEK 89.324%
Cyxone AB (publ) -0.22 SEK -668.182%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 14.646%
Biosergen AB -0.60 SEK -181.667%
Cantargia AB (publ) -1.65 SEK -2.424%
NextCell Pharma AB -1.03 SEK -64.078%
Xspray Pharma AB (publ) -6.76 SEK 75.0%
Elicera Therapeutics AB (publ) -0.83 SEK -103.614%
Nanologica AB (publ) -2.05 SEK 17.561%
SynAct Pharma AB -6.64 SEK 74.548%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -550.0%
Stayble Therapeutics AB (publ) -0.92 SEK -83.696%
LIDDS AB (publ) -0.63 SEK -168.254%
Lipum AB (publ) -4.45 SEK 62.022%
BioInvent International AB (publ) -5.02 SEK 66.335%
Alzinova AB (publ) -0.41 SEK -312.195%
Oncopeptides AB (publ) -1.96 SEK 13.776%
Pila Pharma AB (publ) -0.47 SEK -259.574%
Guard Therapeutics International AB (publ) -11.26 SEK 84.991%
Scandinavian ChemoTech AB (publ) -1.13 SEK -49.558%
Simris Alg AB (publ) -0.16 SEK -956.25%
Diamyd Medical AB (publ) -1.60 SEK -5.625%
Xbrane Biopharma AB (publ) -1.27 SEK -33.071%
Ascelia Pharma AB (publ) -3.24 SEK 47.84%
Diagonal Bio AB (publ) -0.32 SEK -428.125%